OBJECTIVE: To assess the efficacy of a lipid-based nose ointment in treating allergic rhinitis.
STUDY DESIGN AND SETTING: Prospective, open, randomized, controlled clinical study in the outpatient departments of 2 tertiary care centers.
RESULTS: No specific adverse effects were observed. The nose ointment under investigation led to a significant improvement in sneezing and nasal itching (17 patients). There was no significant change for nasal congestion and rhinorrhea in the intention-to-treat sets. However, there was still a significant drop of the mean relative total symptom score derived from the individual scores. All scores remained unchanged in the untreated control group (16 patients).
CONCLUSION: Topical application of the nose ointment as a supportive treatment leads to a significant improvement of symptoms in allergic rhinitis.
SIGNIFICANCE: The prevalence of allergic rhinitis is about 10% to 20% in the population. Our study results are encouraging and should be assessed in further research because changes in the therapeutic guidelines may be suggested.
Get full access to this article
View all access options for this article.
References
1.
MygindNDahlR.Epidemiology of allergic rhinitis. Pediatr Allergy Immunol1996;7(Suppl 9):57–62. (Grade C).
2.
NathanRAMeltzerEOSelnerJC. Prevalence of allergic rhinitis in the United States. J Allergy Clin Immunol1997;99:808–14. (Grade C).
3.
BousquetJVan CauwenbergePKhaltaevN. Management of allergic rhinitis and its impact on asthma (ARIA). J Allergy Clin Immunol2001;108:S147–334. (Grade B).
4.
BachertCBorchardUWediB. Leitlinie der DGAI zur allergischen Rhinokonjunktivitis. Allergologie2003;26:147–62. (Grade B).
5.
BachertCLangeB.Das Management der allergischen Rhinits und ihr Einfluß auf das Asthma. Allergologie2002;25:7–18. (Grade C).
6.
BousquetJLundVJVan CauwenbergePBremard-OuryC. Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial. Allergy2003;58:733–41. (Grade A).
YoungMJBresnitzEAStromBL.Sample size nomograms for interpreting clinical studies. Ann Intern Med1983;99:248–51. (Grade A).
9.
Van CauwenbergePBachertCPassalacquaG. International Rhinitis Management Working Group. International consensus report on the diagnosis and management of rhinitis. Allergy1994; 49(Suppl 9):5–34. (Grade B).
BufeA.A simple advice for the prevention of pollen induced allergic rhinitis. Int Arch Allergy Immunol2000; 121: 85–6 (Grade C).
12.
Van CauwenbergePBachertCPassalacquaG. Consensus statement on the treatment of allergic rhinitis. Allergy2000;55:116–34. (Grade B).
13.
OlzeHWustrowTPUGrigorovA.Provokationstest mit Immerfit Pollenschutzcreme bei Patienten mit allergischer Rhinitis, Erfahrungsheilkunde (Heidelb)2002; 51: 416–21. (Grade B).
14.
SchwetzSOlzeHMelchisedechS. Efficacy of pollen blocker cream in the treatment of allergic rhinitis. Arch Otolaryngol Head Neck Surg2004;130:979–84. (Grade A).
15.
BachorEDostPUngerA. Paraffinoma—A rare complication following endonasal surgery. Laryngorhinootologie1999;78:307–12. (Grade D).
16.
BrownACSlocumPCPutthoffSL. Exogenous lipoid pneumonia due to nasal application of petroleum jelly. Chest1994;105:968–9. (Grade D).
17.
HuxleyEJViroslavJGrayWR. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med1978; 564–8. (Grade C).
